The DayOne Accelerator has helped launch more than 40 innovative healthtech ventures since we started operating in 2018. You can find details of all our active alumni companies below.
Portfolio
In the spotlight
Oncoustics
Oncoustics applies AI to raw sound signals on low-cost ultrasound devices turning these into powerful virtual biopsy tools that will democratize diagnostics.
FindMeCure / Trialhub
TrialHub: Insights that turn trials into treatments.
Theremia
Theremia is an AI-driven platform that optimizes drug development by ensuring pharmaceutical companies create the right drug for the right population subgroups.
Risklick
Revolutionizing clinical trial protocol with first-in-class AI software.
Senseera Health
Senseera’s goal is to transform precision medicine for every patient and pioneer liver diagnostics through groundbreaking chromatin epigenomics.
Portfolio
Company
Therapeutic areas
Country
Funding Stage
Development stage
Docuply
Therapeutic area: z-Other
Country: Germany
Funding Stage: Seed
Development stage: Commercial launch
z-Other
Germany
Seed
Commercial launch
epHealth
Therapeutic area: Cardiovascular diseases, Chronic diseases, Hypertension, Infectious diseases, Metabolic Diseases, Oncology, Rare Disease, Respiratory Diseases
Country: United Kingdom
Funding Stage: Seed
Development stage: Design & development
Cardiovascular diseases, Chronic diseases, Hypertension, Infectious diseases, Metabolic Diseases, Oncology, Rare Disease, Respiratory Diseases
United Kingdom
Seed
Design & development
Ephion health
Therapeutic area: Chronic diseases, Rare Disease, Rehabilitation
Country: Spain
Funding Stage: Seed
Development stage: Regulatory approval & launch prep
Chronic diseases, Rare Disease, Rehabilitation
Spain
Seed
Regulatory approval & launch prep
Exploris Health
Therapeutic area: Cardiovascular diseases, Oncology
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
Cardiovascular diseases, Oncology
Switzerland
Serie A
Commercial launch
FindMeCure / TrialHub
Therapeutic area: Autoimmune diseases, Oncology, Rare Disease
Country: United Kingdom
Funding Stage: Serie A
Development stage: Commercial launch
Autoimmune diseases, Oncology, Rare Disease
United Kingdom
Serie A
Commercial launch
Hope Care
Therapeutic area: Cardiovascular diseases, Chronic diseases, Pulmonology
Country: Portugal
Funding Stage: Serie A
Development stage: Commercial launch
Cardiovascular diseases, Chronic diseases, Pulmonology
Portugal
Serie A
Commercial launch
IBDrelief
Therapeutic area: Bowel diseases, Chronic diseases, Gastroenterology
Country: United Kingdom
Funding Stage: Seed
Development stage: Commercial launch
Bowel diseases, Chronic diseases, Gastroenterology
United Kingdom
Seed
Commercial launch
iLoF
Therapeutic area: Chronic diseases, Neurology, Oncology
Country: United Kingdom
Funding Stage: Serie A
Development stage: Regulatory approval & launch prep
Chronic diseases, Neurology, Oncology
United Kingdom
Serie A
Regulatory approval & launch prep
InSilicoTrials Technologies
Therapeutic area: Disease-agnostic, z-Other
Country: Italy
Funding Stage: Serie A
Development stage: Commercial launch
Disease-agnostic, z-Other
Italy
Serie A
Commercial launch
IntellEEGent
Therapeutic area: Neurology, Pediatrics, Sleep
Country: Switzerland
Funding Stage: Pre seed
Development stage: Design & development
Neurology, Pediatrics, Sleep
Switzerland
Pre seed
Design & development
